Literature DB >> 6446448

Susceptibility of anaerobic bacteria in vitro to 23 antimicrobial agents.

V T Bach, H Thadepalli.   

Abstract

589 isolates of anaerobic bacteria, including 127 isolates of Bacterioides fracilis, were tested against 23 antimicrobial agents. At their usually achievable serum levels, carbenicillin, ticarcillin, mezlocillin and piperacillin; cefoxitin, minocycline, doxycycline, clindamycin, chloramphenicol and rifampin were effective against more than 80% of B. fragilis isolates. At usual therapeutic doses, penicillin (PEN), ampicillin (AMP), cyclacillin (CYC), cephalothin (CT), cefazolin (CZ), cephradine (CPD), cefamandole (CMD), cefaclor (CCL), cefuroxime (CRX), spectinomycin (SPT), tetracycline (TET), ethambutol (EMB) and isoniazid (INH) were ineffective against B. Fragilis. However, high and clinically tolerated doses of PEN, CMD and SPT inhibited more than 80% of B. fragilis isolates, but AMP, CYC, CT, CZ, CPD, CCL and CRX, TET, EMB and INH remained totally ineffective against B. fragilis. The therapeutic merits of these antibiotics are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6446448     DOI: 10.1159/000237926

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  9 in total

1.  Identification and susceptibility patterns of anaerobic bacteria isolated from clinical specimens during a one-year period.

Authors:  A C Rodloff; G Görtz; H Ponnath; H Hahn
Journal:  Infection       Date:  1984 Nov-Dec       Impact factor: 3.553

2.  [Systemic mezlocillin prophylaxis in elective colon surgery].

Authors:  M Wenzel; M Walden; M Heinrich; B Neuhaus
Journal:  Infection       Date:  1982       Impact factor: 3.553

3.  In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.

Authors:  H Thadepalli; U Reddy; S K Chuah; F Thadepalli; C Malilay; R J Polzer; N Hanna; A Esfandiari; P Brown; S Gollapudi
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

4.  Use of lymphokines in treatment of experimental intra-abdominal abscess caused by Bacteroides fragilis.

Authors:  S V Gollapudi; A Gupta; H Thadepalli; A Perez
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

5.  Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess.

Authors:  H Thadepalli; S V Gollapudi; S K Chuah
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

6.  [Antibiotic resistance of anaerobic bacteria (author's transl)].

Authors:  W Niederau; U Höffler; G Pulverer
Journal:  Infection       Date:  1982       Impact factor: 3.553

7.  Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species.

Authors:  K E Aldridge; C V Sanders; A Janney; S Faro; R L Marier
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

8.  Suppression of Clostridium difficile by normal hamster cecal flora and prevention of antibiotic-associated cecitis.

Authors:  K H Wilson; J Silva; F R Fekety
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

Review 9.  Identification and Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Rubik's Cube of Clinical Microbiology?

Authors:  Márió Gajdács; Gabriella Spengler; Edit Urbán
Journal:  Antibiotics (Basel)       Date:  2017-11-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.